Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: April 14, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 24, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Journal: Journal of the American College of Cardiology
Published: October 11, 2016
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Journal: JAMA
Published: November 20, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026